Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : SDL, Inc. [Nasdaq: SDLI] -- Ignore unavailable to you. Want to Upgrade?

To: pat mudge who wrote (3226)	10/24/2000 9:16:30 PM
From: N. David Lessani	Respond to of 3951

Response of SDLI to FDA trading.etrade.com@NEWS-P2&NewsWire=PS

To: pat mudge who wrote (3226)	10/25/2000 12:43:41 AM
From: Red Dragon	Read Replies (1) \| Respond to of 3951

KEY QUESTION: Why the divergence between NT and SDLI reports? When Lucent announced lousy earnings, everyone passed it off as company specific, rather than industry specific. Nortel's shortfall is much more of a shock. At first, the seasonality excuse sounds plausible. However, SDLI, Corning, and Juniper had no problems smashing estimates and all showed strong sequential growth with no seasonality slowdown. Something is not matching. Lucent and Nortel are big customers of SDLI and GLW. How could both LU and NT have disappointing quarters, but SDLI and GLW shine? Finally, just to clarify, is it true that Nortel had a quarterly sequential decrease in optical revenue ? If so, that is worrisome indeed. Even taking seasonality into account, F/O growth should be robust enough not to see any sequential declines. And again, it's not matching with SDLI's report, which saw 33% sequential increase in revenue from prior quarter.